Brief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Tue 11:55
BRIEF-Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada Nov 10 (Reuters) - Abbott Laboratories ABT.N:
ABBOTT - ANNOUNCES AVAILABILITY OF PANBIO COVID-19/FLU A&B SELF-TEST IN CANADA
Source text: ID:nCNWFttMQa
Further company coverage: ABT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement